atx-ms-1467
Peptideexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2010 (NCT01097668)
Timeline
Indications
Mechanism of action
- Myelin basic proteinSupplementation
MBP supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- atx-ms-1467
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01973491 | Phase 2 | Feb 1, 2014 | Merck KGaA |
| NCT01097668 | Phase 1 | Mar 1, 2010 | Apitope, Aptiv Solutions, ClinStar, LLC, University of London |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Apitope | For profit | 1 | 1 | 1 | 2010 |
| Aptiv Solutions | For profit | 1 | 0 | 1 | 2010 |
| ClinStar, LLC | For profit | 1 | 0 | 1 | 2010 |
| Merck KGaA | For profit | 1 | 1 | 1 | 2014 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2010 |
5 organizations
Page 1 / 1